en

PRODUCT DETAIL

Xefo 4 mg/ml

Code 55590
MA number 29/0598/08-S
Product Form: plv iol 1x8 mg+1x2 ml solv. (liek.inj.skl.jantár.+amp.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
MAH, country: Takeda Pharma A/S, Denmark
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-S
M01AC Oxicams
M01AC05 Lornoxicam
Shelf life: 36
Container: glass vial
Route of admin.: Intramuscular or intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 10.11.2008
SPC: SPC_ Xefo 4 mg-ml_09.2023.pdf  
PIL: PIL_Xefo 4 mg-ml_09.2023.pdf  
Safety feature Yes
Data update: 12.09.2018
eu-flag.png sk-flag.png